This information
collection request is approved for three years, as requested.
However, OMB notes that in developing the survey, CMS conducted
several site visits and pretested more than nine individuals
without obtaining prior OMB approval, in violation of the PRA. CMS
must report this violation to OMB in its annual ICB
submission.
Inventory as of this Action
Requested
Previously Approved
09/30/2006
09/30/2006
2,200
0
0
550
0
0
0
0
0
CMS has implemented the Pharmacy Plus
Initiative in grant waivers to states to provide pharmacy benefits
to low-income elders with incomes too high to qualify for medicaid.
This study will evaluate the Pharmacy Plus programs initiated in
the states of Illinois and Wisconsin using a variety of methods
including a descriptive program evaluation, survey of participants,
analyses of drug utilization and costs as well as the cost impact
to the Medicare and Medicaid programs.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.